Frequency of infusion-related reactions with CPX-351 treatment in an observational study in adults with newly diagnosed therapy-related AML or AML with myelodysplasia-related changes (AML-MRC).

ABSTRACT:

SUBMITTER: Jacoby MA 

PROVIDER: S-EPMC9102836 | biostudies-literature | 2021 Oct

REPOSITORIES: biostudies-literature